Ipsen initiates share buy-back program to cover its free performance share allocation plan

Ipsen (Euronext: IPN; ADR: IPSEY), announces today that it has appointed Natixis to purchase 160,000 Ipsen SA shares, or about 0.2% of the share capital, for a period of at least 2 months. The shares purchased under this agreement will be mainly allocated to cover its free performance share allocation plan.

This program is made pursuant to the authorization granted by the Combined Shareholder’s meeting held on June 7, 2017.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019